Recent advances in nanotechnology have made significant progress in biomedical sciences. However, there are growing concerns that exposure to naturally-occurring and synthetic nano-sized particles promotes various types of human diseases. The lungs are the vital organ for gas exchange. Due to their unique position, the lungs can be the primary route that nanoparticles (NPs) enter the human body, which exerts toxic effects. In spite of the wide applications of NPs, the precise effects on health following exposure are not fully understood. To address this, the biophysical properties of naturally-occurring and synthetic NPs, their pathological effects on the respiratory system and the potential human health risk are examined. The goal of this review is to provide the current evidence that exposure to NPs is a risk factor to develop human diseases. The understanding of the pathological process by NPs is essential in preventing and the treatment of nanoparticle-induced human diseases.
|Original language||English (US)|
|Journal||Nanomedicine: Nanotechnology, Biology, and Medicine|
|State||Published - Oct 2020|
Bibliographical noteFunding Information:
This study was supported by the University of Minnesota Medical School Faculty Research Award and Center for Lung Science and Health [CLSH] grant [to RSN].
© 2020 Elsevier Inc.
- innate and adaptive immunity
- naturally occurring and synthetic nanoparticles
- tissue injury
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't